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ABSTRACT
The eukaryotic DNA replication initiation factor
Mcm10 is essential for both replisome assembly
and function. Human Mcm10 has two DNA-binding
domains, the conserved internal domain (ID) and the
C-terminal domain (CTD), which is specific to meta-
zoans. SIRT1 is a nicotinamide adenine dinucleotide
(NAD)-dependent deacetylase that belongs to the
sirtuin family. It is conserved from yeast to human
and participates in cellular controls of metabolism,
longevity, gene expression and genomic stability.
Here we report that human Mcm10 is an acetylated
protein regulated by SIRT1, which binds and
deacetylates Mcm10 both in vivo and in vitro, and
modulates Mcm10 stability and ability to bind DNA.
Mcm10 and SIRT1 appear to act synergistically for
DNA replication fork initiation. Furthermore, we
show that the two DNA-binding domains of Mcm10
are modulated in distinct fashion by acetylation/
deacetylation, suggesting an integrated regulation
mechanism. Overall, our study highlights the im-
portance of protein acetylation for DNA replication
initiation and progression, and suggests that SIRT1
may mediate a crosstalk between cellular circuits
controlling metabolism and DNA synthesis.
INTRODUCTION
Eukaryotic cells initiate DNA replication from multiple
origins that are scattered along the chromosomes. The
initiation of chromosomal DNA replication is a
convergence point for signalling pathways co-ordinating
cellular proliferation (1–4). The activation of replication
origins is a two-step mechanism that begins with the
ordered formation of a macromolecular protein complex
referred to as the pre-replicative complex (preRC) during
late mitosis and early G1 (1–4). At this stage, replication
origins are bound by the origin recognition complex
(ORC), which serves as a platform for sequential
assembly of the initiator proteins Cdc6, Cdt1 and
Mcm2–7 into preRCs in a process commonly known as
‘origin licensing’. The second step is dependent on the ac-
tivation of cyclin-dependent kinases and the Cdc7/Dbf4
kinase complex, which promote the transition from
preRCs to pre-initiation complexes in a temporally
regulated manner throughout S phase. This step, also
referred to as ‘origin ﬁring’, involves the recruitment to
origins of Mcm10, Cdc45 and additional initiator proteins
that collectively are capable of promoting DNA origin
unwinding and recruiting DNA polymerases (1–4).
Current research in yeast and metazoans has clearly
demonstrated that Mcm10 is essential for DNA replica-
tion initiation (1–4). The human replication initiation
factor Mcm10 is a multifunctional protein that interacts
with DNA and replisome protein components (5–15). Free
Mcm10 has also been reported to stabilize DNA polymer-
ase a-primase by formation of a soluble complex, which in
co-operation with And1/Ctf4 complex is then targeted to
origins (16,17). Human Mcm10 has two DNA-binding
domains: the conserved internal domain (ID) and the
C-terminal domain (CTD, speciﬁc to metazoans), both
capable of binding single-stranded DNA (ssDNA)
(18–21). After replication initiation, Mcm10 remains
associated with the migrating DNA replication fork and
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inactivation or depletion of Mcm10 inhibits S-phase pro-
gression (22). Mcm10-knockdown cells exhibit slower
early and mid, and aberrantly late, S-phase DNA replica-
tion (23). Prolonged Mcm10 depletion leads to Chk1-
dependent DNA damage response and subsequent
apoptosis (24). Human Mcm10 forms a hexameric ring
that appears to serve as a docking module between
critical replication factors necessary for origin ﬁring (10).
However, apart from reports on cell cycle-dependent
phosphorylation of Mcm10 (8,13) and on the requirement
of di-ubiquitination for binding to PCNA protein (25),
little is known about the functional regulation of Mcm10.
Acetylation of proteins appears to be one of the most
conserved post-translational modiﬁcations across all life
domains, and its counterbalance by deacetylation is now
accepted as a common regulatory event in the modulation
of stress response, transcription activation and enzymatic
activity, chromatin structure, DNA repair and stability of
many proteins (26–29). SIRT1 is a human homologue of
yeast Sir2. It belongs to the family of sirtuins that are
conserved from yeast to human. SIRT1 is a class III
histone deacetylase (HDAC) that catalyses the removal
of acetyl moiety from the e-amino groups of conserved
lysine residues in histones in nicotinamide adenine di-
nucleotide (NAD)-dependent manner (30,31). The seven
human sirtuins differ in their subcellular localization.
SIRT1, SIRT6 and SIRT7 are predominantly nuclear,
whereas SIRT2 is mainly cytoplasmic, though it can be
shuttled to the nucleus during mitosis (32,33). SIRT3,
SIRT4 and SIRT5 are located in mitochondria. SIRT1
has been implicated in the control of chromatin structure,
transcription and DNA repair, serving as a crucial link
between cell metabolism, control of genomic stability, lon-
gevity and aging (30,31,34,35). Sir2 has been shown
to negatively regulate a subset of DNA replication
origins (20%) in Schizosaccharomyces pombe by affect-
ing preRC assembly (36–38). Sir2 in Saccharomyces
cerevisiae has also been implicated in controlling the
timing of replication origins by reprogramming them
from early to late (39). Although protein interactions
between Mcm10 and Sir2 have been reported in yeast,
their signiﬁcance remains unexplored in human cells
(40–42). In humans, SIRT1-dependent deacetylation has
been reported to modulate the DNA-binding properties of
important proteins that are regulated by acetylation/
deacetylation. The list of SIRT1 targets includes the tran-
scription factors p53, E2F1, FOXO1 and FOXO3a, and
the DNA repair proteins Ku70, WRN, NBS and XPA
(43–48).
In this study, we explored the interactions between
Mcm10 and SIRT1 in human cells and their functional
implications. We demonstrate that (i) Mcm10 is an
acetylated protein and (ii) SIRT1 interacts directly
with Mcm10 and modulates its DNA binding and stability
via deacetylation. This novel regulatory mechanism
suggests that, like transcription and DNA repair factors,
human DNA replication proteins are also modulated
by acetylation/deacetylation and this could be import-
ant during assembly, initiation and function of the
replisome.
MATERIALS AND METHODS
Recombinant DNA plasmids and proteins
Plasmids coding for Flag-SIRT1 (pCDNA3.1-Flag-
hSIRT1) and GST-SIRT1 (pGEX-5X-hSIRT1) were
obtained from Prof. Fuyuki Ishikawa and Dr. Nobuyuki
Tanimura (Kyoto University, Japan). pCDNA3.1-p300
(49) and pCDNA3.1-vectors coding for Flag-SIRT2,
SIRT5, SIRT6 and SIRT7 (50) were all obtained from
Addgene, with Addgene plasmid numbers 23252, 13813,
13818, 13817, 13818, respectively. SIRT2, SIRT5, SIRT6
and SIRT7 cDNAs were used to subclone into pGEX-6P1
and pGEX-6P3 vectors to generate GST fused SIRT2, 5,
6 and 7.
Full length (FL) of Mcm10 was expressed similar to the
previously described (10). N-terminal domain (NTD) (aa
1–223), ID (aa 224–466) and CTD (aa 630–874) of Mcm10
were subcloned into pProEX-HT-B expression vector
(Invitrogen). Expression of H6-Mcm10 protein and its
domains was induced with 1mM Isopropyl b-D-1-
thiogalactopyranoside (IPTG) in Escherichia coli strain
Rosetta (Novagen) for 12 h at 15C. Cells were lysed in
25mM Tris–HCl, pH 9.0, 500mM NaCl, 10mM MgCl2,
25mM KCl, 10% glycerol. The proteins were isolated by
Ni++ metal afﬁnity chromatography, eluted with 25mM
Tris–HCl, pH 7.5, 150mM NaCl, 10mM MgCl2, 25mM
KCl buffer containing 250mM imidazole and further
puriﬁed by gel ﬁltration, aliquoted, ﬂash-frozen in liquid
nitrogen and stored at 80C. Commercial preparates of
SIRT1 and p300 HAT were obtained from BioMol
(ENZO Life Science). Acetyl-CoA (AcoA), NAD and
NIA were all obtained from Sigma.
Cell cultures, transfections and siRNA
HCT116 cells were cultivated in McCoy 5A growth
medium (GIBCO) supplemented with 10% foetal bovine
serum (FBS) and antibiotics (penicillin/streptomycin).
Plasmid DNA was transfected using LipofectamineTM
2000 (Invitrogen) according to manufacturer’s instruction.
For RNA interference (RNAi), non-targeting small
interfering RNA (siRNA) (siRNA #1) and SIRT1
siRNA were obtained from Dharmacon, while Mcm10
siRNA was obtained from Applied Biosystems.
Exponentially growing cells in a six-well plate format
were transfected with siRNA complex prepared in
OptiMEM (Invitrogen) and transfected using
LipofectamineTM RNAiMAX (Invitrogen) according to
manufacturer’s instructions. Cells were incubated for add-
itional 48 h (unless stated otherwise) and the silencing of
proteins was conﬁrmed by western blot (WB).
SIRT1-siRNA sequence was 50-ACUUUGCUGUAACC
CUGUA-30 and Mcm10-siRNA sequence was 50-CGGCG
ACGGUGAAUCUUAU-30.
Cell synchronization and extract fractionation
Cells were grown to 40% of conﬂuence in six-well plates,
changed into medium containing 2mM thymidine and
incubated for further 24 h, after which they were washed
with phosphate buffered saline (PBS) containing 2mM
thymidine, transfected with anti-SIRT1 or control
4066 Nucleic Acids Research, 2013, Vol. 41, No. 7
 at U
CL Library Services on June 27, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
siRNA and further incubation in Mc-Coy medium con-
taining 2mM thymidine without antibiotics. Twenty-four
hours post-transfection cells were washed once with 2ml
of PBS plus 2mM thymidine and placed into fresh
Mc-Coy medium with 10% FBS, 1% antibiotics and
2mM thymidine. After further 12 h, cells were washed
with PBS and incubated in thymidine-less McCoy
medium with 10% FBS and antibiotics. Cells then were
harvested at different time points following the release
from the thymidine block. At those points, cells were har-
vested, washed with PBS and centrifugated (1400 rpm,
4C, for 2 min). After discarding supernatant, cell pellet
was resuspended in 200ml of Buffer A [10mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES),
pH 7.9, 10mM KCl, 1.5mM MgCl2, 0.34M sucrose,
10% glycerol, 1mM dithiothreitol (DTT), 0.1% Triton
X-100, protease inhibitor cocktail (Roche)] and incubated
on ice for 8 min. After that, samples were centrifuged at
3700 rpm, 4C, for 5 min. The supernatant was separated
into the fractions S1 (cytoplasmic fraction) and pellet
fraction P1 (nuclear fraction). Fraction S1 was then
further clariﬁed by centrifugation at 13 200 rpm, 4C, for
5 min and its supernatant was collected into the S2
fraction, which contained soluble cytoplasmic protein.
Fraction P1 was washed once with 200 ml of Buffer A
and resuspended by pipetting in 150 ml of Buffer B [3
mM ethylenediaminetetraacetic acid (EDTA), 0.2mM
ethylene glycol tetraacetic acid (EGTA), 1mM DTT,
protease inhibitor cocktail (Roche)]. The fraction then
was further incubated for 30 min on ice and centrifuged
at 4300 rpm, 4C, for 5 min. Separated supernatant
(fraction S3) contained nuclear soluble proteins and the
pellet (fraction P3) contained chromatin. Pellet (P3) was
washed once with 150 ml of Buffer B and resuspended in
80 ml of Buffer B plus 0.5 ml of the Benzonase enzyme
(Novagen), and samples were incubated at room tempera-
ture for 15 min. Samples were then aliquoted, ﬂash-frozen
in liquid nitrogen, stored at 80C, and used for further
analysis.
Immunoprecipitation and western blot analysis
Samples were prepared for immunoblotting by lysis in
Radio-Immunoprecipitation Assay buffer (RIPA) buffer
[0.1% sodium dodecyl sulphate (SDS), 50mM Tris-HCl
(pH 7.5), 1% sodium deoxycholate, 1% nonyl phenoxypo-
lyethoxylethanol (NP-40), 1mM EDTA, protease inhibi-
tor cocktail (Roche), (150mM NaCl or 300mM NaCl,
low or high stringency, respectively)]. For immunopre-
cipitation (IP), clariﬁed RIPA cell lysates were incubated
with relevant primary antibody overnight at 4C. The re-
sultant immunocomplexes were precipitated by incubation
with Protein A sepharose (GE Healthcare). After sufﬁ-
cient wash, samples were analysed by WB. Samples were
resolved on 4–12% 3-(N-morpholino)propanesulfonic
acid (MOPS) gels (Invitrogen) and transferred onto nitro-
cellulose membrane with a semidry apparatus for 1 h at
15V. Membrane was blocked in PBS containing 10% milk
and 0.2% Tween-20 and probed with the required
antibodies.
Mcm10 antibody was raised in rabbit against
N-terminus (1–279 aa) of Mcm10 and immunopuriﬁed
(Eurogentec), whereas the other antibodies were
purchased from commercial sources as indicated. SIRT1
antibody (Santa Cruz biotechnology, USA), anti-Flag
(Sigma), gH2AX (Upstate); anti-a-tubulin, His-tag,
GST-tag, acetyl-lysine (K-Ac), H3K9-Ac and histone H3
antibodies were all purchased from Abcam. Antibody
signals were detected with ECL Chemiluminescent
Substrate (Pierce). Anti-mouse and anti-rabbit secondary
antibodies were from (Dako Denmark A/S).
Molecular combing
Forty-eight hours after transfection with siRNA, HCT116
cells were pulse labelled for 20min with 100 mM IdU
(Sigma), quickly washed with PBS and pulse labelled for
another 20min with 100 mM CldU (Sigma). Cells were
then trypsinized, embedded in low melting agarose plugs
and treated as described (51,52). Brieﬂy, after cell lysis and
agarose digestion, DNA ﬁbers were combed on silanized
coverslips, denatured with NaOH and replicons were
detected with anti-IdU and anti-CldU antibodies.
Images of replicated DNA were captured using the epi-
ﬂuorescence microscope Pathway (Becton Dickinson) with
Attovision software. Signals were measured using ImageJ
(NCI, NIH) with custom-made modiﬁcations. For the cal-
culation of fork velocities, only replicons with signals that
had similar length for IdU and CldU were considered, to
exclude the possibility of broken or arrested forks. If not
speciﬁed, a minimum number of 200 replicons were
analysed to generate each histogram for fork velocities,
and 50 couples of adjacent replicons for the inter-origin
distances.
GST pull-down assay
GST and GST-tagged sirtuin proteins were expressed and
puriﬁed from bacteria using standard methods. Equimolar
quantities of puriﬁed proteins were conjugated to
glutathione-Sepharose beads and incubated with different
puriﬁed Mcm10 domains. Beads were incubated for 1 h at
+4C with rotation, washed extensively, then 50 ml of
loading buffer (3) containing DTT to reduce disulphide
bonds and SDS were added to the samples. The samples
were boiled at 95C for 5min and analysed using 4–12%
MOPS gels (Invitrogen) followed by WB with either
anti-His or anti-GST antibodies. Bound Mcm10 protein
was quantiﬁed relative to SIRTs input using densitometry
(AlphaEase FC software).
In vitro acetylation and deacetylation assays
In vitro acetylation assays were set as advised by the
manufacturer of recombinant p300 HAT (BioMol,
ENZO Life Science) and as described in (53). Brieﬂy,
target proteins (1 mg of NTD, ID, CTD or 3 mg
of Mcm10 FL were incubated for 60min at 30C
with AcoA (ﬁnal 0.33mM) and 0.5mg of p300 HAT
(5.7 m/mg). SIRT1-dependent deacetylation assays reac-
tions were set as advised by the manufacturer of SIRT1
(BioMol, ENZO Life Sciencev). Subsequent deacetylation
assays were started as described above to acetylate protein
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substrates for 1 h at 30C, then 0.5mg of commercial
SIRT1 (BioMol, ENZO Life Science) or 1 mg of
GST-SIRT1 and 1mM of NAD and incubated for
further 45min at 30C. Deacetylation reactions were
blocked by addition of NIA to 50mM ﬁnal concentration.
All reactions were stopped by boiling at 95C for 5min
and analysed using 4–12% MOPS gels (Invitrogen)
followed by WB with anti-K-Ac antibody.
Mass spectrometry
Following in vitro (de)acetylation assays, recombinant
Mcm10 protein products (ID and CTD) were each
separated by SDS polyacrylamide gel electrophoresis
and visualized by silver-staining (ProteoSilver Plus,
Sigma Aldrich, Poole, UK). Bands corresponding to the
correct molecular weight for each product were excised
from the gel, destained and processed with the Progest
Investigator instrument (Digilab, Huntingdon, UK)
using established protocols for reduction and alkylation
(54). Gel plugs were rehydrated in 20 mg/ml sequencing
grade modiﬁed trypsin (Promega, Southampton, UK)
and incubated overnight at 37C. Tryptic peptides were
eluted, vacuum-dried, resuspended in 0.1% formic acid
and analysed by liquid-chromatography mass spectrom-
etry performed with an LTQ-Orbitrap Classic mass spec-
trometer (Thermo Fisher Scientiﬁc, UK). Details of mass
spectrometry and subsequent data analysis can be found
in Supplementary Methods.
Electromobility shift assay
Sixty-nucleotide long ssDNA: 50-TGCCAAGCTTGCAT
GCCTGCAGGTCGACTCTAGAGG-30 was used for
band shift experiments. The DNA was 50-labelled with
33[P] using T4 Polynucleotide Kinase (Promega) and
[g-33P]ATP for 1 h at 36C. Labelled DNA was puriﬁed
with ‘‘NTP wash’’ kit Qiagen and the DNA has been
checked on 20% TBE gel run in 1 TBE at 160V.
DNA-binding properties of Mcm10 and its acetylated/
deacetylated domains were studied by electrophoretic
mobility shift assay. The ﬁnal volume of DNA-binding
mixtures was 20 ml, of which the DNA template was typ-
ically 4 ml (20mg/ml) and the remaining volume was made
of the protein sample (NTD 1 mg, ID 1 mg, CTD 1 mg, FL
0.5mg, SIRT1 1 mg or p300 0.5 mg) and the reaction buffer
(25mM Tris–HCl, pH 8.0, 2mM DTT, 50mM NaCl,
2.5mM of MgCl2). Whenever p300 and/or SIRT1 were
present, reactions were supplemented with AcoA and/or
NAD+, respectively.
The reactions were incubated for 10min at room tem-
perature when direct protein–DNA interaction was tested,
60min at 36C when acetylated Mcm10 proteins were
tested and further 40min at 36C when an additional in-
cubation with SIRT1 took place. All samples were kept
for 20min on ice before loading onto 6% 0.5 TBE
Novex DNA Retardation gels (Invitrogen). A volume of
5 ml of 6 DNA loading buffer (Promega) was added
before loading the samples onto 6% 0.5 TBE Novex
DNA Retardation gels (Invitrogen). After running at
90V in 0.5 TBE at 4C, gels were dried and analysed
by autoradiography. The radioautography images
obtained after exposure were scanned and densitometric
analysis of the protein-shifted DNA bands was performed
using AlphaEasePC software.
Flow cytometry (FACS) analysis
Before harvesting cells, BrdU was added to a ﬁnal concen-
tration of 10 mM for 1 h. Cells were then collected, washed
with PBS containing 3% bovine serum albumin and
prepared for analysis using the APC BrdU ﬂow kit (BD
PharmingenTM) according to manufacturer’s procedure.
The stained cells were analysed for total DNA (7AAD
incorporation) and BrdU incorporation using the
FlowCyan ADP machine (Becton Dickinson). Data were
analysed with the Summit 4.3 software.
RESULTS
Human Mcm10 speciﬁcally interacts with SIRT1 in vivo
To determine whether human Mcm10 and sirtuin proteins
speciﬁcally interact with each other, we tested Mcm10’s
interaction with SIRT1, SIRT2, SIRT5, SIRT6 and
SIRT7. SIRT1 and SIRT2 have been reported the most
robust deacetylases (50,55). We transiently expressed
Mcm10 in combination with each of these different
sirtuins in human cells. All sirtuins were Flag-tagged to
allow their precipitation, whereas Mcm10 was
immunoprecipitated by polyclonal anti-Mcm10
antibody. Mcm10-SIRTs complexes formed in vivo were
isolated by IP with either anti-Mcm10 or anti-Flag
antibodies, and complexes were analysed by immunoblot-
ting (Figure 1A and B).
As shown in Figure 1A (left panel), Flag-SIRT1 was the
only SIRT that efﬁciently co-precipitated with Mcm10.
Conversely, for the ﬁve different SIRTs tested, Mcm10
was only co-precipitated with Flag-SIRT1 (Figure 1B,
top panel), indicating that Mcm10 speciﬁcally interacts
with SIRT1. The SIRT1–Mcm10 interaction was highly
speciﬁc, as none of the other sirtuins (SIRT2, SIRT5,
SIRT6 and SIRT7) was efﬁciently co-precipitated with
Mcm10 under the same conditions (Figure 1A and B).
SIRT1 interacts with the C-terminus of Mcm10
We next analysed whether the SIRT1–Mcm10 interaction
was direct using recombinant GST-tagged sirtuins in vitro
(Figure 1C). Recombinant Mcm10 was found to bind spe-
ciﬁcally to SIRT1. Only SIRT6 among the other sirtuins
showed some low-level interaction with Mcm10
(Figure 1Ci and ii).
Further analysis of Mcm10 derivatives showed that
SIRT1 selectively strongly interacted with the CTD of
Mcm10 (residues: 636–874), the domain which is speciﬁc
to metazoan Mcm10 and absent in the yeast protein
ortholog (Figure 1D). This CTD has two additional
Zn-ﬁnger motifs located at the C-terminal end and has
been reported to bind ssDNA (16,17). We therefore tested
whether these Zn-ﬁnger motifs were required for SIRT1–
Mcm10 association and whether the presence of ssDNA
would affect their interaction. As shown in Figure 1E,
neither EDTA nor ssDNA affected SIRT1–Mcm10
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complex formation, indicating that the interaction between
these two proteins requires an epitope different from
Zn-ﬁnger motifs and can potentially take place when
Mcm10 is bound to DNA.
Mcm10 is an acetylated protein and is deacetylated by
SIRT1 in vivo
The interaction between Mcm10 and SIRT1 suggested
that Mcm10 could be a substrate for SIRT1 deacetylase
activity. To test this hypothesis, we ﬁrst determined
whether Mcm10 is acetylated in vivo. As shown in
Figure 2A, acetylated endogenous Mcm10 was readily
detected by immunoblotting for acetylated lysine (K-Ac)
after IP with Mcm10 antibody, demonstrating that en-
dogenous human Mcm10 is acetylated in vivo. Notably,
endogenous SIRT1 also co-precipitated with Mcm10 on
Mcm10 IP (Figure 2A). The immunoprecipitated
acetylated Mcm10 migrated as a range of subspecies
close to each other, suggesting that (i) more than one
domain of Mcm10 might be acetylated and/or (ii)
multiple lysine residues might be acetylated in each
domain (Figure 2A).
To test whether SIRT1 deacetylates Mcm10 in vivo, we
examined the effect of SIRT1 overexpression in human
cells. HCT116 cells were transiently transfected with
both Mcm10- and SIRT1-expressing constructs, and
complexes of these two proteins were immunoprecipitated
with anti-Mcm10 antibody. As demonstrated in
Figure 2B, the level of immunoprecipitated acetylated
Mcm10 was decreased when SIRT1 was overexpressed.
This Mcm10 deacetylation was coincident with a reduc-
tion of the total Mcm10 levels, suggesting that acetylation
may regulate Mcm10 stability. Next we tested whether
RNAi-mediated SIRT1 knockdown could reverse this
trend. Using small double-stranded interfering RNA
(siRNA) to silence SIRT1 expression (as monitored by
WB analysis), we found that acetylation of Mcm10 was
signiﬁcantly increased by SIRT1 knockdown (Figure 2C).
The reduction of the SIRT1 deacetylase activity on
silencing was also evident from the higher levels of
acetylated lysine residue K9 of histone H3 (H3K9),
which is a well-established target of SIRT1 (Figure 2C).
Two domains of Mcm10 can be acetylated and
deacetylated in vitro
We next examined whether Mcm10 can be acetylated
in vitro. Puriﬁed FL Mcm10 and its NTD, ID and CTD
(see Figure 1D) were incubated with recombinant p300
HAT. As shown in Figure 3A incubation of FL Mcm10
and three of its domains with p300 HAT in the presence of
AcoA resulted in strong acetylation of the FL Mcm10,
and of its isolated ID and CTD domains. The NT
domain of Mcm10 showed no detectable acetylation by
p300 HAT under similar conditions despite having a sig-
niﬁcant number of lysine residues. Furthermore, in vitro
deacetylation assays using puriﬁed human SIRT1 in the
presence of its co-factor NAD+ or its inhibitor NIA con-
ﬁrmed that Mcm10 is a substrate for SIRT1 (Figure 3B
and C).
We next performed mass spectrometry analysis of the
in vitro acetylated/deacetylated Mcm10 and its domains
(Table 1 and Supplementary Table S1). The analysis
indicated that of four lysine residues acetylated by p300
in the ID, two residues could be speciﬁcally deacetylated
by SIRT1. Furthermore, p300 acetylated nine single lysine
residues and eight lysine pairs in the CTD, of which four
single lysines and six pairs were speciﬁcally deacetylated
by SIRT1 (Table 1 and Supplementary Table S1).
Collectively, these data show that SIRT1 modulates the
acetylation status of Mcm10 via its deacetylase activity
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Figure 1. SIRT1 interacts with Mcm10 in vivo and in vitro. (A and B)
HCT116 cells were co-transfected with plasmids (3 mg each) encoding
His-tagged Mcm10 and Flag-tagged sirtuins. Anti-Mcm10 and
anti-Flag immunoprecipitates (IP) were analysed by WB with the
indicated antibodies. Co-immunoprecipitations indicated that Mcm10
interaction was speciﬁc to SIRT1. Arrows indicate SIRT1 on left
panel in A, and Mcm10 on the top panel in B. (B) Input panel
shows signals obtained with both anti-Mcm10 and anti-Flag antibodies.
Mcm10 is indicated with asterisk. (C) GST-fused sirtuin proteins
coupled to Sepharose beads were incubated with recombinant
Mcm10. After beads were washed, bound proteins were analysed by
WB with anti-Mcm10 antibody (i). The input proteins were analysed
with anti-GST antibody (ii), and the relative binding of sirtuins to
Mcm10 was compared with SIRT1 (iii). (D) GST-fused SIRT1 bound
to Sepharose beads was incubated with different His-tagged deletion
mutants of Mcm10, which represented its separate NTD, ID and CTD.
SIRT1 interacting Mcm10 domains were identiﬁed by WB with
anti-His antibody. Strong and weak interactions were observed for
CTD and ID, respectively. (E) Sepharose beads with bound
GST-SIRT1 were incubated with Mcm10 CTD in the presence of
either EDTA or ssDNA (60 nt). Neither condition affected Mcm10
interaction with SIRT1.
Nucleic Acids Research, 2013, Vol. 41, No. 7 4069
 at U
CL Library Services on June 27, 2014
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
targeting its two lysine-rich domains, the conserved ID
and the metazoan-speciﬁc CTD. Acetylation and
deacetylation of Mcm10 modulate its DNA binding.
Because the ID and CTD of Mcm10 can both be
acetylated by p300 and deacetylated by SIRT1 in vitro
(Figure 3) and are known DNA-interacting domains, we
examined the effect of acetylation and deacetylation on
the DNA-binding properties of these domains.
Electrophoretic mobility assays (EMSA) with a 60-nt
long ssDNA probe were used for these experiments.
Figure 4 shows that the puriﬁed recombinant CTD efﬁ-
ciently binds ssDNA (lanes 2 and 3). This DNA binding,
however, was reduced (2.5-fold) on acetylation by p300
(Figure 4A, compare lanes 2 and 3 with 4 and 5, and
Supplementary Figure S1A, bars 2 and 3). On the other
hand, addition of SIRT1 to deacetylate the CTD restored
DNA binding (Figure 4A, lanes 6 and 7, and
Supplementary Figure S1A, bars 3 and 4). A small
increase in CTD DNA binding was observed when
SIRT1 was present in the reaction with NAD+ (10%,
Figure 4A, lanes 8 and 9, and Supplementary Figure S1A,
bars 2 and 5). No signiﬁcant change of DNA-binding ef-
ﬁciency of CTD was observed in the presence of
substrateless SIRT1 (Supplementary Figure S2).
A different set of results was obtained when the ID
of Mcm10 was tested under identical conditions.
The interaction of this domain with DNA was minimal
when the non-modiﬁed ID was used, but greatly enhanced
on addition of p300 to the reaction mix (3.5-fold,
Figure 4B, lanes 2 and 3 compared with lanes 4 and 5,
and Supplementary Figure S1B, bars 2 and 3).
Interestingly, this increased DNA-binding ability was
not affected by the subsequent deacetylation by SIRT1
(Figure 4B, lanes 6 and 7, and Supplementary Figure
S1B, bars 3 and 4). Furthermore, the presence of SIRT1
increased DNA binding of ID 2-fold (Figure 4B, lanes 8
and 9, and Supplementary Figure S1B, lanes 2 and 5).
Finally, when the FL Mcm10 was tested, addition of
p300 to the reaction mix increased its DNA-binding
property (6.5-fold, Figure 4C, compare lanes 2 and 3
with lanes 4 and 5, and Supplementary Figure S1C, bars
2 and 3). Moreover, the DNA binding of Mcm10 was
A B C
Figure 2. SIRT1 deacetylates Mcm10 in vivo. (A) Acetylated Mcm10 protein can be immunoprecipitated with anti-Mcm10 antibody from HCT116
cells. (Top panels) Left panel shows positive signal with anti-Mcm10 antibody, middle panel with anti-K-Ac antibody and right panel showing
endogenous SIRT1 also co-precipitated with Mcm10. Control reactions with IgG did not immunoprecipitate Mcm10. Blots were subjected to long
exposure to show all speciﬁc and non-speciﬁc protein bands. Acetylated Mcm10 migrated as a subspecies close to each other, suggesting multiple
acetylation sites. (B) HCT116 cells were transfected with plasmids that express His-Mcm10 and Flag-SIRT1. Protein levels were determined with
direct WB (input), whereas detection of Mcm10 acetylation was determined by IP of the protein with anti-Mcm10 antibody followed by WB using
indicated antibodies (anti-Mcm10 and anti-K-Ac). (C) HCT116 cells were co-transfected with plasmids that express His-Mcm10 and Flag-SIRT1 and
either siSIRT1 or control siRNA. Acetylation of Mcm10 and all protein levels were determined in a similar way to those in panel B.
A B C
Figure 3. SIRT1 deacetylates Mcm10 in vitro. (A) Mcm10 is acetylated by p300 in vitro. Puriﬁed FL human Mcm10 and its three main domains
(NTD, ID and CTD) were incubated for 45min at 30C with the recombinant p300 in the presence or absence of AcoA. Reaction products were
analysed by WB with anti-K-Ac antibody as indicated. p300 can acetylate the FL Mcm10, its internal core domain and C-terminus, with the latter
most efﬁciently acetylated. (B) SIRT1 deacetylates Mcm10 in vitro in NAD-dependent manner. The acetylation reaction products were further
incubated for 45min with the recombinant human SIRT1 in the presence or absence of NAD. (C) SIRT1-dependent deacetylation of Mcm10 and its
domains can be inhibited by NIAThe reactions were performed in a similar way to those in (B) with addition of NIA, which speciﬁcally blocked
SIRT1 activity and Mcm10 deacetylation.
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further enhanced by SIRT1-mediated deacetylation
(1.5-fold, Figure 4C, lanes 6 and 7, and Supplementary
Figure S1C, bars 3 and 4). The FL Mcm10 protein DNA
binding was not affected by the addition of SIRT1 (with
NAD+), which has slightly enhanced the DNA binding of
Mcm10 ID (Figure 4B and C, lanes 8 and 9). Presumably
some epitopes of the ID may be less accessible for SIRT1
interaction within hexameric assembly of Mcm10 and/or
this interaction may be less efﬁcient and provide less effect
at the gel-shift conditions.
In parallel with the EMSA experiments, we examined
whether acetylation and/or deacetylation of the Mcm10
domains took place under conditions used for the
EMSA experiments. Aliquots of the samples loaded
onto EMSA gels were resolved on 4–12% PAAG gels
and immunoblotted with anti-K-Ac antibody
(Figure 4D, lanes 1, 3, 4 and 5). The analysis showed
that the presence of ssDNA did not interfere with
p300-mediated acetylation of the CTD, and the domain
was acetylated by p300 regardless of whether the DNA or
p300 was added ﬁrst to CTD (Figure 4D, top panel).
These results suggest that either the acetyltransferase can
compete for lysine residues on the Mcm10 CTD when it is
bound to DNA, or that not all lysine residues targeted by
p300 are involved in DNA binding. Furthermore, when
SIRT1 was added to the reactions, it could deacetylate
CTD lysines in the absence or presence of DNA, and
also when DNA was added to the solution before or
after SIRT1. These results indicated that samples
resolved on lanes 4 and 5 of the EMSA experiment
(Figure 4A) contained acetylated CTD, and the CTD
resolved on lanes 6 and 7 was deacetylated (Figure 4A).
On the contrary, the ID pre-incubated with ssDNA was
not accessible for acetylation (Figure 4D, lane 2, bottom
panel). The ID was acetylated less efﬁciently when p300
HAT was given a ‘‘head-start’’ before the addition of
ssDNA (Figure 4D, lane 3, bottom panel). The subsequent
addition of SIRT1 could efﬁciently deacetylate the ID
regardless of the presence of DNA.
SIRT1 depletion affects Mcm10 levels on and off
chromatin
Having demonstrated a SIRT1-dependent effect on
Mcm10 binding to DNA in vitro, we tested the effect of
SIRT1 knockdown on Mcm10 binding to chromatin
in vivo. To that end, HCT116 cells were ﬁrst synchronized
by thymidine block for 24 h, followed by RNAi (transfec-
tion with siSIRT1 or control siRNA) for another 24 h,
after which the medium was replaced with thymidine-
only-containing medium, and cells were incubated
further for 12 h until their release into S-phase and
sample collection during the next 8 h (Figure 5A).
We ﬁrst analysed the levels of the nuclear soluble
Mcm10 (Figure 5B). At time point zero, just before the
release into the S-phase, the levels of Mcm10 were higher
when SIRT1 was depleted, and these higher levels per-
sisted throughout the time course, whereas Mcm2
appeared unchanged (Figure 5B). These results are con-
sistent with those shown in Figure 2C showing that SIRT1
depletion resulted in slight increase of total Mcm10 in
asynchronous cell culture. Notably, the time points that
spanned S-phase and the beginning of G2/M phase
showed an extra band (Mcm10*) reactive with anti-
Mcm10 antibody and running just under the main band
Table 1. Mcm10 lysine residues acetylated by p300 and deacetylated by SIRT1 in vitro, as determined by mass spectrometry of the recombinant
Mcm10 domains
Mcm10 domain Lysine (K) residues
acetylated by p300
Lysine (K) residues still
acetylated after SIRT1 treatment
Lysine (K) residues
deacetylated by SIRT1
ID
K267 K267
K312 K312
K318 K318
K390 K390
CTD
K657 K657
K664 K664
K681 K681
K683 K683
K745 K745
K761 K761
K768 K768
K783 K783
K853 K853
CTD (double sites)
K681+K682 K681+K682
K737+K739 K737+K739
K847+K849 K847+K849
K868+K874 K868+K874
K683+K685 K683+K685
K674+K682 K674+K682
K674+K681 K674+K681
K668+K674 K668+K674
Acetylated lysine residues that are targets for SIRT1 deacetylation are in bold. Supplementary Table S1 contains additional information regarding
protein probability scores, sequence coverage and peptide sequences for each Mcm10 product.
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of Mcm10 (Figure 4B). This Mcm10* specie was especially
prominent at the end of the S-phase but disappeared when
cells treated with the control siRNA entered G2/M, sug-
gesting that it might correspond to a differently post-
translationally modiﬁed Mcm10, e.g. Mcm10 with low
phosphorylation status, which is known to accumulate
at the end of S-phase and is subsequently being destroyed
during G2 (8,13). This was not the case, however, for cells
with depleted SIRT1. The Mcm10* species slowly
accumulated throughout the time course and did not dis-
appear, suggesting that the absence of SIRT1 might
change Mcm10 post-translational modiﬁcation dynamics
and turnover (Figure 4B).
The analysis of chromatin-bound Mcm10 showed that
again, in cells with depleted SIRT1, higher levels of
Mcm10 were associated with chromatin from the begin-
ning to the end of the time course, whereas Mcm2 levels
remained unchanged (Figure 4C). Only a small and rela-
tively unchanged amount of Mcm10* (or similar) species
was present on chromatin.
SIRT1 and Mcm10 depletion affect cell cycle and DNA
replication
Having demonstrated a speciﬁc interaction between
Mcm10 and SIRT1 and SIRT1-dependent modulation of
A B
C D
Figure 4. Acetylation and deacetylation modulate properties of Mcm10
DNA-binding domains in a distinct way. 33[P]-labelled ssDNA of 60 nt
length was used for EMSA analysis. Puriﬁed Mcm10 or its domains
were ﬁrst incubated in the presence or absence of p300 and AcoA,
and/or SIRT1 and NAD under conditions identical to those shown
in Figure 3. Reaction mix containing either acetylated or deacetylated
Mcm10 (or its domain) was then incubated with ssDNA and protein–
DNA complexes formed were analysed on 6% Polyacrylamide gel
(PAAG). (A) Acetylation negates DNA binding of CTD. Untreated
CTD efﬁciently formed complexes with DNA (lanes 2 and 3),
whereas acetylated CTD did not (lanes 4 and 5). Deacetylation by
SIRT1 restored DNA binding by CTD (lanes 6 and 7). Addition of
SIRT1 (and NAD+) to CTD did not substantially enhance its DNA
binding (lanes 8 and 9). Neither p300 nor SIRT1 formed complexes
with ssDNA on their own (lanes 10 and 11, respectively). (B)
Acetylation of the ID of Mcm10 enhanced its DNA binding (lanes 4
and 5 compared with 2 and 3). Subsequent deacetylation with SIRT1
did not negate it (lanes 6 and 7). (C) Acetylation of the FL Mcm10
stimulated DNA-complex formation (lanes 2 and 3), which was further
enhanced by subsequent deacetylation with SIRT1 (lanes 6 and 7).
Lane 1 on all gels—DNA probe without any protein. (D) DNA inter-
feres with acetylation of ID but not CTD of Mcm10. DNA was added
to Mcm10 domains before or after addition of p300/AcoA or SIRT1/
NAD+. Products of reactions were analysed by WB with anti-K-Ac
antibody, similar to Figure 3. Lanes 3 and 6 represent reactions iden-
tical to those used for EMSA. The presence of DNA inhibited acetyl-
ation of ID when added before p300 (lane 2).
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Figure 5. Depletion of SIRT1 modulates Mcm10 levels on and off
chromatin. HCT116 cells were synchronized by the thymidine block,
treated with anti-SIRT1 and control siRNAs in the presence of thymi-
dine, and released into S-phase with samples collected during the next
8 h (A). Cell extracts were fractionated to analyse nuclear soluble and
chromatin-bound proteins (B and C). The levels of nuclear soluble
Mcm10 were higher when SIRT1 was depleted compared with respect-
ive samples obtained from cells treated with control siRNA, whereas
levels of Mcm2 and tubulin were unchanged (right versus left panels,
B). Notably, the levels of a post-translationally modiﬁed form of
Mcm10 (Mcm10*) that migrated below Mcm10 accumulated during
the S-phase were lower when control cells entered G2/M (time points
6 and 8 h, left panel, B). However, this Mcm10* specie did not dis-
appear during G2/M in cells with depleted SIRT1 (right panel, B). The
analysis of chromatin-bound Mcm10 shows that higher levels of
Mcm10 are associated with chromatin from the beginning to the end
of the time course in cells with depleted SIRT1, whereas Mcm2 levels
and histone 3 (H3) remained unchanged (C).
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Mcm10 binding to DNA, we next analysed the effects
of Mcm10 and/or SIRT1 knockdown on overall DNA
synthesis and cell cycle. For this purpose, we performed
RNAi-mediated knockdown of Mcm10 and SIRT1 indi-
vidually and together. DNA synthesis and total DNA
were analysed 48 h after siRNA transfection (Figure 6).
Mcm10 knockdown produced a signiﬁcant decrease
(>2-fold) in the number of S-phase cells (Figure 6B and
E). This was accompanied by an increase in G1-phase cell
population and a small decrease in G2/M-phase cell popu-
lation (Figure 6B). These results suggest that Mcm10
knockdown diminishes overall DNA synthesis (BrdU
uptake), which is consistent with Mcm10 role as an essen-
tial DNA replication initiation factor. SIRT1 knockdown
also produced a signiﬁcant change in cell cycle proﬁle
(Figure 6C) with a substantial (2-fold) increase in the
G2/M-phase cell population, while the S-phase cell popu-
lation remained relatively unchanged (Figure 6C and E).
Simultaneous knockdown of both Mcm10 and SIRT1
resulted in 2-fold reduction in the number of S-phase
cells and an increase of the G1 population, which was
similar to the effects of knocking down Mcm10 alone
(Figure 6D and E). In addition, Mcm10 depletion, either
alone or in combination with SIRT1 knockdown resulted
in a pronounced reduction in overall DNA synthesis
(BrdU uptake) (Figure 6B, D and E). Longer (72 h)
post-transfection incubation resulted in signiﬁcant cell
death for both Mcm10 and SIRT1 depletions (not shown).
To test the possibility that Mcm10 and/or SIRT1 deple-
tion resulted in DNA damage, we monitored the
phosphorylated form of histone H2AX (gH2AX) (56).
Accumulation of gH2AX was evident in all three cases
and was at highest level when both Mcm10 and SIRT1
were simultaneously depleted (Figure 6F), indicating the
induction of DNA damage on SIRT1 and Mcm10
depletion.
SIRT1 and Mcm10 depletion affects origin activation and
replication fork velocity
To investigate the effect of Mcm10 and/or SIRT1 deple-
tion on DNA replication, we used a single DNA molecule
approach based on DNA combing (51,57,58). Human
Mcm10 and SIRT1 were silenced in HCT116 cells by
siRNAs individually and simultaneously, as described
above. Representative images of replication signals are
shown in Figure 7A for cells treated with control siRNA
(top) and for cells simultaneously knocked down for
SIRT1 and Mcm10 (bottom). Distances between replica-
tion origins and fork velocities were calculated and the
analysis is reported in Figure 7B and C, respectively.
The inter-origin distances decreased slightly when
Mcm10 was knocked down. Thus, >60% of the inter-
origin distances in this sample were lower than the mean
value of the control (Figure 7B). SIRT1 depletion did not
change the value of inter-origin distances. When both
proteins were knocked down simultaneously, we
observed a strong reduction of inter-origin distances,
with the mean value reduced from 120 kb to 92 kb
(P< 0.001) (Figure 7B).
The average velocity of replication forks remained rela-
tively unchanged when Mcm10 was knocked down, and
went slightly up to 1.53 kb/min (P< 0.01) in cells trans-
fected with siRNA targeting SIRT1, showing that forks
tend to accelerate when SIRT1 protein levels are reduced
(Figure 7C). In contrast, when both SIRT1 and Mcm10
were depleted at the same time, fork velocity went signiﬁ-
cantly downward from 1.35 to 1 kb/min (P< 0.001),
indicating that simultaneous knockdown of Mcm10
and SIRT1 slows down replication fork progression
(Figure 7C, bottom panel). The reduction in fork
velocity and inter-origin distance in cells with simultan-
eous knockdown of Mcm10 and SIRT1 coincided with
higher level of DNA damage as monitored by induction
of gH2AX (Figure 6F).
DISCUSSION
Our study shows that human Mcm10 is an acetylated
protein regulated by SIRT1, which speciﬁcally binds and
deacetylates Mcm10 both in vivo and in vitro. The inter-
action between Mcm10 and SIRT1 can be mapped to the
CTD of Mcm10; however, it does not require C-terminal
Zn-ﬁnger motifs and does not interfere with DNA binding
(Figure 1). Importantly, both DNA-binding domains of
Mcm10, ID and CTD can be acetylated by p300 HAT,
with the CTD being the more efﬁcient recipient of the
modiﬁcation at least in vitro (Figure 3 and Table 1). The
prediction of lysine acetylation sites in Mcm10 by the
PAIL software suggests there are multiple possible
targets in both lysine-rich ID and CTD parts of Mcm10
protein (59,60). This was further conﬁrmed by the mass
spectrometry analysis of recombinant Mcm10 domains
acetylated by p300 (Table 1).
The subsequent SIRT1-catalysed deacetylation of either
domain can be blocked by the addition of NIA, an in-
hibitor of sirtuins, thus conﬁrming the speciﬁc nature of
the reaction (Figure 3). Similarly, SIRT1-dependent
deacetylation in vivo can be diminished by depleting
SIRT1 levels with siRNA (Figure 2). Moreover, SIRT1
speciﬁcally deacetylated a set of lysine residues within
ID and CTD Mcm10 domains when tested in vitro
(Table 1).
We also analysed the effect of acetylation and
deacetylation of Mcm10 (and its domains) on DNA
binding. Interestingly, the experiments showed that the
two DNA-binding domains of Mcm10 are modulated in
distinct fashion. Acetylation of the Mcm10 ID stimulates
DNA binding, whereas acetylation of the CTD inhibits
DNA binding. However, the latter can be restored by
SIRT1-dependent deacetylation of CTD (Figure 4).
Chromatin recruitment of Mcm10 was also affected
when SIRT1 was depleted by siRNA during S-phase,
that is, more Mcm10 was loaded and retained on chroma-
tin throughout the S-phase consistently with the overall
higher levels of Mcm10 on SIRT1 silencing (Figure 5).
Additionally, we also investigated the global effect
of Mcm10 and SIRT1 depletion by siRNA on the
cell cycle and DNA replication. Depletion of Mcm10
led to an aberrant S-phase and drastic decrease of
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Figure 6. Depletion of SIRT1 affects DNA replication. FACS analysis of HCT116 cells after depletion of Mcm10 and/or SIRT1 levels with siRNAs.
Cell cycle proﬁle and BrdU incorporation of HCT116 cells 48 h after being transfected with (A) control siRNA, (B) siMcm10, (C) siSIRT1, (D) both
Mcm10 and SIRT1 siRNAs. (E) Comparison of BrdU incorporation levels (active DNA synthesis) in HCT116 cells after Mcm10 and/or SIRT1
depletion. (F) Induction of gH2AX in cells with downregulated Mcm10 and/or SIRT1.
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BrdU-incorporating S-phase population, whereas SIRT1-
depleted cells showed slight increase in S-phase cell
population and signiﬁcant accumulation in G2/M phase.
DNA damage signalling resulting from Mcm10 and/or
SIRT1 depletion suggested that replication forks were
not efﬁciently stabilized and/or repaired when DNA rep-
lication was initiated under those conditions (Figure 6).
Furthemore, when both SIRT1 and Mcm10 were
depleted, cells experienced problems with both initiation
and progression of DNA synthesis (Figures 6 and 7),
suggesting that Mcm10–SIRT1 partnership may function
in both the initiation and the elongation phases of DNA
replication.
SIRT1 role in Mcm10 regulation
Previous studies in yeast have demonstrated that yeast
Mcm10 can interact with Sir2 and act as a bridge to link
Sir2 to other components of the DNA replication machin-
ery; however, it has not been shown whether Mcm10 is a
A
B C
30
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20
15
10
5
0
Figure 7. Depletion of Mcm10 and SIRT1 affects origin activation and replication fork velocity. (A) Representative images of combed DNA ﬁbres.
(B) Inter-origin distances were measured on individual DNA molecules from HCT116 cells transfected with indicated siRNAs. (C) Fork velocity was
measured as the average of contiguous IdU- and CldU-labelled tracks divided by their pulse time (20min each). Mean values are indicated,
respectively, for fork velocity and for inter-origin plots. Red dashed lines indicate median values for control HCT116 cells transfected with
control siRNA.
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subject of Sir2-dependent deacetylation (40–42). Our data
now indicate that the Sir2 human ortholog, SIRT1, plays
a direct regulatory role in DNA replication in human cells
by modifying Mcm10.
Collectively, our data suggest a model of acetylation/
deacetylation-dependent regulation of Mcm10 DNA
binding (Figure 8A). Acetylation could be required for
the initial DNA binding via the conserved ID (in
keeping with the data in Figure 4B), possibly at the
stage of the replisome assembly. It is also possible that
the acetylation of some lysine residues in the ID
sequence may serve as a temporary block that directs
this domain (and Mcm10) into a certain type of inter-
action with DNA and/or proteins and then can be
removed to allow a next step interaction during
multiprotein replisome complex assembly. For example,
the acetylation of lysine residues in the ID may promote
the binding of Mcm10 to DNA via its OB (oligonucleotide
/oligosaccharide binding)-fold domain using hydrophobic
interactions. Subsequent deacetylation of the ID bound to
DNA would not affect the DNA complex stability and
may unprotect lysine residues that can then either serve
to provide an additional interaction with DNA or par-
ticipate in protein–protein interaction within the DNA
replication complex. The following SIRT1-dependent
deacetylation of the CTD may then fully potentiate the
DNA-binding capacity of Mcm10.
In addition to the DNA-binding modulation of Mcm10
by SIRT1, our data suggest that deacetylation may also
unprotect lysine residues that are otherwise ubiquitinated
marking Mcm10 for degradation (Figure 8B). Consistent
with this, the overexpression of SIRT1 led to decrease of
Mcm10 levels (Figure 2). This observation is also consist-
ent with a recently published report that the C-terminal
part of Mcm10 is required for its degradation (61,62).
Furthermore, the depletion of SIRT1 led to stabilization
of the Mcm10 levels overall and especially during mitosis
(Figure 5), indicating that SIRT1 plays an important role
in regulating Mcm10 degradation.
SIRT1 role in regulation of DNA replication
There are a number of recent reports on the importance of
protein acetylation in regulation of DNA replication.
Thus, in yeast, acetylation of multiple lysine residues on
histone H3 and H4 tails facilitates origin ﬁring (28).
However, local histone acetylation does not reﬂect origin
efﬁciencies in mammalian ﬁbroblasts, at least in euchro-
matic transcribed regions (63). Nevertheless, DNA repli-
cation origin licensing by Cdt1 and Mcm2–7 loading in
human cells is mediated by HBO1, Orc1 interacting
acetyltransferase, which acetylates histone H4 (64–66).
Furthermore, recent reports showed that cohesin acetyl-
ation facilitates replication fork processivity, deacetylation
of Cdt1 by HDAC11 regulates its stability, acetylation of
Cdc6 modulates its phosphorylation and acetylation of
DNA2 and FEN1 regulates their nuclease activity (67–70).
Previous studies in yeast have demonstrated
Sir2-dependent negative regulation of a subset of DNA
replication origins (36,38). These studies suggested an in-
volvement of Sir2, at least indirectly via remodelling chro-
matin, in early steps of preRC assembly most likely
through its deacetylase activity. Our results show that,
on its own, SIRT1 depletion increases replication fork
velocity, but a simultaneous depletion of SIRT1 and
Mcm10 signiﬁcantly reduces replication fork velocity
and inter-origin distance.
DNA molecular combing and cell cycle analyses dem-
onstrate that the depletion of Mcm10 deregulates origin
activation and leads to DNA damage signalling and re-
duction of cell numbers in S-phase (Figures 6 and 7, re-
spectively). Depletion of SIRT1 on the other hand leads to
DNA damage and higher fork velocity (Figures 6F
and 7B). This acceleration may result from chromatin
being more relaxed due to the lack of SIRT1, and thus,
Ac Ac
+ DNA
+ SIRT1Ac
Ac Ac
DNA
ID
DNA
Mcm10
NTD ID CTD
Ac Ac cA cAcA
H/KATDNA-binding ?
Regulation ?
Protection ?
Degradation ?
SIRT1 DNA-binding ?Regulation ?
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B
Figure 8. Schematic model of the Mcm10 regulation by acetylation
and SIRT1. (A) Acetylation of Mcm10 promotes DNA binding of
the conserved ID, but negates DNA binding of the metazoan-speciﬁc
CTD. The acetylation of ID serves for the initial Mcm10 loading onto
DNA via its OB-fold domain, with further deacetylation of CTD
needed to stabilize the complex and provide additional Mcm10-DNA
and Mcm10-protein contacts. (B) Deacetylation of Mcm10 at CTD
could also deprotect it from ubiquitination.
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forks encounter less hindrance during progression.
Additionally the depletion of SIRT1 might directly or in-
directly affect acetylation/deacetylation balance of
cohesins, thus again, facilitating fork progression. It is
also possible that lack of SIRT1 activity shifts the
balance in timing of origin ﬁring similar to what has
been observed in yeast rendering late origins to ﬁre
earlier (36–39).
The simultaneous depletion of Mcm10 and SIRT1
appears to act in a synergistic manner and results in sig-
niﬁcant slowing down of forks, higher DNA-damage
signalling and drastic reduction of inter-origin distances
(Figure 7), resulting most likely from the activation of
dormant origins within the same replisome clusters
(51,71–74). A possible reason for such synergistic effect
of the simultaneous Mcm10/SIRT1 knockdown is that
the individual knockdowns were not complete and left
enough of respective protein targets to initiate DNA rep-
lication origins. The amount of deacetylated Mcm10 was,
however, severely decreased when both Mcm10 and
SIRT1 were depleted. Taken together, this suggests that
deacetylation of Mcm10 by SIRT1 is one of the important
regulatory events in initiation of forks and that the acetyl-
ation/deacetylation balance of Mcm10 has to be regulated
tightly for both proper fork initiation and progression.
One can envisage that distinct patterns of acetylation/
deacetylation of Mcm10 might be required for the differ-
ent steps of DNA replication.
When this manuscript was in preparation, three reports
were published showing that Mcm10 has a new important
role in DNA replication initiation (75–77). Thus, Mcm10
facilitates the Mcm2–7 promoted origin DNA unwinding
step (75–77). Future experiments will help to establish
whether the SIRT1-dependent deacetylation regulates
this role of Mcm10.
Overall, our ﬁndings demonstrate SIRT1-dependent
regulation of an essential DNA replication factor
Mcm10 and highlight the importance of protein acetyl-
ation for DNA replication. Furthermore, our data
provide a ﬁrst link between DNA replication and sirtuin
deacetylases, suggesting a possible crosstalk between
cellular circuits of the cell cycle, metabolism and DNA
synthesis.
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